Streamlined serialisation means serious savings

By Adents

As global manufacturing regulations tighten to weed out counterfeit drugs from supply chains, suppliers have to come to terms with new demands being placed upon serialisation. World Pharmaceutical Frontiers talks to Jim Cummings, vice-president for the Americas at Adents, about how the company’s Pharma Suite is streamlining new input demands for the production line and helping manufacturers make significant long-term savings.

Enter your details below to view the free white paper

By downloading this White Paper, you acknowledge that may share your information with our white paper partners/sponsors who may contact you directly with information on their products and services.

Visit our Privacy Policy for more information about our services, how Business Trade Media International Limited may use, process and share your personal data, including information on your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.